Abstract
Introduction Informed consent forms (ICFs) for randomised clinical trials (RCTs) can be onerous and lengthy. The process has the potential to overwhelm patients with information, leading them to miss elements of the study that are critical for an informed decision. Specifically, overly long and complicated ICFs have the potential to increase barriers to trial participation for patients with mild cognitive impairment, those who do not speak English as a first language or among those with lower medical literacy. In turn, this can influence trial recruitment, completion and external validity. Methods and analysis SIMPLY-SNAP is a pragmatic, multicentre, open-label, two-Arm parallel-group superiority RCT, nested within a larger trial, the Staphylococcus aureus Network Adaptive Platform (SNAP) trial. We will randomise potentially eligible participants of the SNAP trial 1:1 to a full-length ICF or a SIMPlified LaYered (SIMPLY) consent process where basic information is summarised with embedded hyperlinks to supplemental information and videos. The primary outcome is recruitment into the SNAP trial. Secondary outcomes include patient understanding of the clinical trial, patient and research staff satisfaction with the consent process, and time taken for consent. As an exploratory outcome, we will also compare measures of diversity (eg, gender, ethnicity), according to the consent process randomised to. The planned sample size will be 346 participants. Ethics and dissemination The study has been approved by the ethics review board (Sunnybrook Health Sciences Research Ethics Board) at sites in Ontario. We will disseminate study results via the SNAP trial group and other collaborating clinical trial networks.
Original language | English |
---|---|
Article number | e083239 |
Pages (from-to) | e083239 |
Number of pages | 10 |
Journal | BMJ Open |
Volume | 14 |
Issue number | 1 |
DOIs | |
Publication status | Published - 18 Jan 2024 |
Bibliographical note
Funding Information:The SIMPLY-SNAP trial is funded by project grants from the Canadian Institutes of Health Research (CIHR) (grant number 496741) and the Accelerating Clinical Trials (ACT) Canada Consortium. This trial is conducted as part of the PhD thesis work of SWXO, with funding supported by the University of Toronto Fellowship (UTF), Connaught International Scholarship and the University of Melbourne Graduate Research Scholarship.
Publisher Copyright:
© 2024 BMJ Publishing Group. All rights reserved.